Qlife Holding AB (publ) (STO:QLIFE)

Market Cap	41.24M
Revenue (ttm)	286.00K
Net Income (ttm)	-24.73M
Shares Out	15.68M
EPS (ttm)	-1.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	161,616
Average Volume	342,708
Open	2.730
Previous Close	2.630
Day's Range	2.440 - 2.730
52-Week Range	1.205 - 5.740
Beta	0.62
RSI	52.39
Earnings Date	Feb 11, 2026

About Qlife Holding AB

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vitami, and D-dimer. Qlife Holding AB (publ) was incorporated in 2019 and is based in Helsingborg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2019
• Employees: 1
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: QLIFE

Financial Performance

In 2024, Qlife Holding AB's revenue was 50,000, a decrease of -79.51% compared to the previous year's 244,000. Losses were -55.92 million, -64.37% less than in 2023.